MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Summary

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Interventions

• Electronic Health Record Review · OTHER

  Ancillary studies

• Smartphone Application-based Intervention · BEHAVIORAL

  Receive access to MyCap application

• Survey Administration · OTHER

  Ancillary studies

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Adults ≥ 18 years old
* Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
* English speaking
* Access to a smartphone (Android or iOS)

Exclusion Criteria:

* Prisoners
* Patients undergoing cancer surveillance

Sites (1)

• Ohio State University Comprehensive Cancer Center, Columbus, Ohio · RECRUITING